| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
ING Investment Management Co. (U.S.) is a New York, NY-based company in the Software and Internet sector.
Idestini Dev Studio exists to help you realize the full potential of your business, online. We build websites, mobile applications and custom software, using the right tools for where you are in your business journey. We`re a small studio that creates results-oriented websites and applications. We aim to understand our client`s situations and goals, dream about what the future looks like and then build and implement plans to get there.
Corsetti Design is a Farmington, UT-based company in the Software and Internet sector.
mVentix, Inc. is a Santa Clarita, CA-based company in the Software and Internet sector.